ReviewWorld journal of gastrointestinal endoscopy2025
Advances and future directions in endoscopic bariatric therapies.
Review in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta regression of endoscopic sleeve gastroplasty versus intragastric balloon investigating influence of duration and baseline body mass index.Scientific reports · 2026Pooled it
- Intragastric Balloon Therapy: Short-Term Gains and the Quest for Long-Term Success.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026Article
- Endoscopic Sleeve Gastroplasty: A Qualitative Narrative Review of Outcomes, Safety, and Clinical Applications.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a chronic, multifactorial disease closely linked to a spectrum of cardiometabolic disorders, with its global prevalence rising at an alarming rate. In recent years, minimally invasive, safe, and effective endoscopic bariatric therapies have gained significant attention as alternatives to conventional surgical interventions. This review provides a comprehensive overview of various endoscopic weight-loss procedures, evaluating their advantages and limitations in comparison to surgical approaches to assist clinicians in optimizing patient-specific treatment strategies. Endoscopic bariatric therapies, including intragastric balloons, duodenal-jejunal bypass sleeves, endoscopic sleeve gastroplasty, gastric remodeling procedures, and interventions aimed at delaying gastric emptying are systematically reviewed. The efficacy, safety profiles, and clinical applicability are all synthesized. Endoscopic bariatric therapies exhibit distinct advantages and limitations, with varying indications and contraindications. As part of a multidisciplinary approach to obesity management, these procedures should be integrated with lifestyle modifications and nutritional counseling to maximize therapeutic benefits. Future research should focus on the long-term efficacy, safety, and patient-reported outcomes to refine clinical practice and optimize the role of endoscopic interventions in obesity treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.